"We continue to conclude that the benefits of these medications outweigh their risks when they are used according to the FDA approved labeling," spokesperson Chanapa Tantibanchachai said in an email to NPR
A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with outcomes improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Arizona residents across the state, from Phoenix to Flagstaff and from Tucson to the rural border communities, have real and practical access to tirzepatide today
It comes in a strong concentration of 5mg/ml of Semaglutide and 0.5mg/ml of Cyanocabolamin
This phase acts as an adjustment period, giving your body time to get used to the medications effects on appetite and digestion
In some studies, telomere length rose by an average of 33.3%, though results varied between individuals, likely due to differences in baseline telomerase activity, cellular age, and other metabolic factors [4, 14]
Despite these benefits, GLP-1RAs come with limitations, including high costs, potential side effects, the risk of weight regain, and specific concerns for individuals with eating disorders